Johnson & Johnson (NEO:JNJ)

Market Cap	509.76B
Revenue (ttm)	127.63B
Net Income (ttm)	31.16B
Shares Out	n/a
EPS (ttm)	12.84
PE Ratio	16.36
Forward PE	14.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,375
Average Volume	18,464
Open	20.34
Previous Close	20.46
Day's Range	20.30 - 20.37
52-Week Range	18.75 - 22.50
Beta	0.52
RSI	50.49
Earnings Date	Jul 16, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Cboe Canada
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD